Stockreport
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Financial performance highlights potential challenges and growth opportunities for Gilead Sciences Inc. Detailed examination of Gilead Sciences Inc's strengths, weaknesses, opportunities, and threats to inform investment decisions. Gilead Sciences Inc ( NASDAQ:GILD ) recently filed its 10-Q report on November 12, 2024, providing a snapshot of the company's financial health and strategic positioning. The report reveals a 7% increase in total revenues to $7.5 billion for the three months ended September 30, 2024, compared to the same period in 2023, primarily driven by higher product sales in HIV. However, net income attributable to Gilead saw a significant decrease from $2.2 billion in Q3 2023 to $1.3 billion in Q3 2024, with diluted earnings per share dropping from $1.73 to $1.00. This decline is largely attributed to a substantial in-process research and development (IPR&D) impairment charge related to assets acquired from Immunomedics in 2020. Despite this setback, Gilead Scien
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences, Inc. (NASDAQ: GILD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $125.00 price target on the stock.[MarketBeat]
- Gilead Prices $3.5 Billion of Senior Unsecured Notes[Business Wire]
- Gilead Sciences' (NASDAQ:GILD) Soft Earnings Are Actually Better Than They Appear [Yahoo! Finance][Yahoo! Finance]
- Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow[Business Wire]
- More
GILD
SEC Filings
SEC Filings
- 11/13/24 - Form FWP
- 11/13/24 - Form 424B5
- 11/12/24 - Form 10-Q
- GILD's page on the SEC website
- More